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Protective immunity against mycobacteria is dependent on antigen-specific Th
lymphocytes . It has been assumed that theseTh upon recognition ofantigen/MHC
secrete macrophage-activating factors that enable effector macrophages to eliminate
the intracellular organism (1) .
Recently, however, we have found that mycobacteria are very potent inducers of
antigen-specific CD4+ and CD8+ cytotoxic T (Tc) cells as well as antigen-nonspe-
cific killer cells that lysehuman monocytes (2). Also, in experimental animal models,
evidence has recently accumulated in favor of an important role for Tc cells in the
immune response to mycobacteria (reviewed in reference 3) . In addition, Mycobac-
terium bovis Bacillus Calmette-Guerin (BCG)-reactive human CD4+ T cell clones
have been reported to lyse PPD-pulsed target (antigen-presenting) cells (4) . The
identification ofthe cytotoxic effector cells as well as the antigens that they recognize
are of obvious importance for the design of mycobacterial subunit vaccines .
Here we report that therecombinant65-kD heat shockprotein (HSP) (5) ofM . bovis
BCG, which is identical to the 65-kD protein ofM . tuberculosis, shares >95% sequence
homology with theM . leprae 65-kD gene (6) and shows extensive crossreactivity with
the latter (reference 7) is an immunodominant antigen forCD4+ BCG-specific Tc
cells in a significant number (t 20%) of BCG-responsive individuals. In addition,
recombinant 65-kD HSP-stimulated effector cells also efficiently lysed autologous
monocytes in the absence of antigen . This observation may shed new light on the
role of the 65-kD HSP in autoimmunity .
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Materials and Methods
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Lymphocyte Transformation Test (LTT).
￿
Ficoll-isolated PBMC of 58 mainly Ethiopian indi-
viduals were cultured with BCG, purified protein derivative (PPD) (both from StatensSerum
The Armauer Hansen Research Institute (AHRI) was founded by the Norwegian and Swedish Save
The Children Funds, and is now supported by the Swedish International Development Agency and
the Norwegian Development Agency. This work was also supported by National Institutes of Health
grant ROl CA-44882-1 and AI-20198-3 . AHRI is affiliated with the All Africa Leprosy Rehabilitation
and Training Centre (ALERT), Addis Ababa, Ethiopia .
J. Exp . MED. © The Rockefeller University Press " 0022-1007/88/11/1947/06 $2.00
￿
19471948
￿
OTTENHOFF ET AL.
￿
BRIEF DEFINITIVE REPORT
Inst., Denmark; 5 ug/ml), M. leprae (2 .5 x 107 bacilli/ml; provided by Dr. R. J. W. Rees,
Mill Hill, UK), recombinant 65-kD HSP of BCG (5 ug/ml), or control RPMI 1640 + 5%
normal human serum, pulsed on day 6 with [3H]thymidine, harvested 18 h later, and counted
by liquid scintillation counting (Rackbeta II; LKB Instruments, Inc., Gaithersburg, MD).
Cylotoxiciy Assay.
￿
As described in detail in reference 2, PBMC were stimulated during
7 d with PPD, BCG, or the recombinant 65-kD HSP of BCG in 24-well tissue culture plates
(Linbro; Flow Laboratories, McLean, VA) (106 cells/ml).
Target cells were day 6 adherent cells ofPBMC that had been plated in 96-well U-bottomed
tissue culture plates (1.5 x 105 cells/well) (Titertek; Flow Laboratories). Approximately 10%
of the cells adhered. This number was used for calculating E/T ratios. On day 6, the cells
were pulsed with antigen (PPD, 25 ug/ml; BCG, 25 ug/ml; tetanus toxoid, 1 :120 dilution;
recombinant 65-kD HSP of BCG, 20 kg/ml) and labeled with 2 gCi of 51 sodium chromate
(Amersham International, Amersham, UK) during 18 h and then washed three times with
preheated medium. Effector cells were then added in triplicate to the target cells (150 wl/well).
One triplicate with medium only was used for the determination ofspontaneous release. 15 h
laterthe total supernatant content of each well was transferred to a detachable counting tube
(Linbro; Flow Laboratories) and 100 ul of triton-X was added to the original wells to lyse
the remaining adherent cells. After 3 h the total volume oftriton-X was transferred to similar
tubes and the samples were counted (1270 Rack Gamma; LKB Instruments, Inc.). The
percentage-specific killing for each individual well was calculated as follows: percent specific
lysis = [test cpm/(test cpm + cpm after triton-X treatment of the same well)] x 100% -
percent spontaneous release. The percentage spontaneous release was calculated as follows:
cpm in spontaneous release well/(cpm in spontaneous release well + cpm aftertriton-X treat-
ment of the same well) x 100%.
Depletion ofLymphocyte Subsets with mAb-coatedMagnetic Beads.
￿
Magnetic beads (Dynal A. S.,
Oslo, Norway) were coated with rabbit anti-mouse Ig (Dakopatts, Glostrup, Denmark) and
then incubated with 50 ul of the appropriate second layer mAb (Leu-1 (CD5), Leu-2 (CD8),
Leu-19 (FINK-1) (all from Becton Dickinson & Co., Mountain View, CA), BMA 044 (CD4)
(Behringwerke AG, Marburg, Federal Republic of Germany) or normal mouse serum [con-
trol beads]). Cells and beads were mixed in a 1 :4 ratio, centrifuged for 5 min at 4°C (1,000
rpm), and then incubated for another 15 min on ice. The pellet was gently resuspended and
depleted for marker-positive cells with a magnetic particle concentrator (Dynal A. S.). The
procedure was repeated two more times. Control bead-depleted cells were resuspended in
complete medium to give a 30:1 E/T ratio in the highest concentration. The other cell sus-
pensions were resuspended in the same volume as the control bead-depleted cells. Depletion
was usually 85-100% effective as determined by immunofluorescence.
Results
Proliferative PBMC Responses ofBCG Responder Individuals to the Recombinant 65-kD
HSP ofBCG. PBMC of 47 out of 58 individuals proliferated (i.e., >5,000 cpm)
to BCG. Nine individuals (19%) also responded to the recombinant 65-kD purified
HSP of BCG (Table I).
TheRecombinant6541)HSPofBCGisan Immunodominant Target MoleculeforPPDIBCG-
induced Cytotoxic Elector Cells that Specifically Lyse Antigen-pulsed Monocytes. PPD- or
BCG-stimulated effector cells from recombinant 65-kD responsive donors efficiently
lysed PPD-pulsed, and to a much lower extent, nonpulsed or tetanus toxoid-pulsed
autologous monocyte targets in a dose-dependent manner (Table II). PPD-induced
effector cells of recombinant 65-kD(LTT) responsive donors also lysed recombinant
65-D-pulsed monocytes as efficiently as PPD-pulsed ones. PPD-stimulated effector
cells of a recombinant 65-kD LTT nonresponder lysed PPD-pulsed but not recom-
binant 65-kD-pulsed monocytes (Table II, Exp. 4). The recombinant 65-kD HSP
of BCG, therefore, appears to be an important target molecule for PPD- or BCG-
stimulated cytotoxic effector cellsof recombinant 65-kD LTTresponsive but not non-
responsive donors.OTTENHOFF ET AL .
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TABLE I
Proliferative Responses of PBMC from Different Individuals to M . boais BCG, M. leprae,
and the Recombinant 65-kD HSP of BCG Protein
The results are expressed as mean cpm t SEM of [3H]thymidine incorporation by triplicate cultures of
2 x 10 5 PBMC each . Results are only shown for the 9 out of 47 (21 healthy contacts, 13 BT, and 13 LL
patients) BCG responsive individuals that responded to the recombinant 65-kD protein (see Materials and
Methods) .
* BT, borderline tuberculoid leprosy .
t LL, lepromatous leprosy .
The Recombinant 65-kD HSP ofBCG is an Immunodominant Stimulatory Molecule for
Cytotoxic E_ffector Cells that Lyse bothPPD and Recombinant 65-kD HSP ofBCG-pulsedMono-
cytes . To investigate if the recombinant 65-kD HSP of BCG also was im-
munodominant at the precursor rather than at the effector level, we raised recom-
binant 65-kD-stimulated effector cells from LTTresponsive donors . These effector
cells efficiently lysed recombinant 65-kD-pulsed monocytes and, importantly, also
PPD-pulsed monocytes (Table II) . Nonpulsed or irrelevant antigen-pulsed mono-
cytes were lysed to a lower extent than PPD- or recombinant 65-kD-pulsed ones,
but recombinant 65-K-induced effector cells lysed nonpulsed monocytes muchmore
(roughly twice as) efficiently than did PPD- or BCG-induced cytotoxic cells .
The recombinant 65-kD HSP ofBCG thus is an efficient stimulatory molecule
for precursors of cytotoxic effector cells that specifically lyse PPD- and recombinant
65-kD-pulsed monocytes but also strongly lyse monocytesin theabsence of antigen .
Membrane Phenotype ofPPD and Recombinant 65-kDHSP ofBCG-induced Cytotoxic E~ector
Cells . PPD or recombinant 65-kD HSP of BCG-induced effector cells predomi-
nantly consisted of CD3+/CD5''CD4+ T cells (data not shown) . The depletion of
CD4 but not CD8 or Leu-19+ cells from the effector population reduced or
abrogated lytic activity against both PPD and recombinant 65-kD protein-pulsed
monocytes (Fig . 1) .
Discussion
The 65-kDHSP is amajorimmunogeniccomponentofM. boaisBCG,M . tubercu-
losis, andM . leprae, and is frequently recognized by murine andhumanB cells and
helper T cells (6-8) . Little is known about the possible role of Tc cells in the human
immune response to mycobacteria . We here show that the 65-kD HSP ofM . boais
BCG/M . tuberculosis is an immunodominant target molecule for BCG/PPD-specific
CD4' Tc lymphocytes that lyse human monocytes, and is an immunodominant
No .
Clinical
diagnosis BCG/PPD
Recombinant
65-kD protein M. leprae Control
1 Normal 145,204 ± 8,733 53,710 f 1,989 51,493 f 4,797 821 f 607
2 Normal 162,243 f 19,895 12,229 t 3,674 66,261 t 6,333 2,208 t 306
3 Normal 60,607 t 11,584 9,989 t 3,497 19,507 t 2,381 540 t 122
4 Normal 172,745 t 14,839 20,585 f 5,305 ND 1,116 ± 453
5 Normal 140,741 f 4,314 5,906 t 6 8,093 f 2,955 1,633 t 466
6 BT* 55,735 f 7,758 10,504 t 2,011 56,140 t 11,884 2,369 t 812
7 BT 61,260 t 11,991 5,796 t 508 23,711 t 4,057 1,834 ± 811
8 BT 53,524 t 22,786 22,535 t 3,286 5,807 ± 1,264 2,863 t 851
9 LL1 59,357 t 12,137 21,901 t 5,175 955 t 98 1,202 t 2241950
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TABLE II
Antigen -specific and Antigen-nonspecific Lysis of Monocyte Targets by BCG/PPD or
Recombinant 65-kD HSP of BCG-stimulated Cytotoxic Effector Lymphocytes
Exp .
2
3
4
Results are expressed as the mean percentage specific lysis of triplicate cultures calculated as described in
Materials and Methods . SEM were mostly <107o .
LTT index, cpm in antigen-stimulated cultures/cpm in nonstimulated cultures .
1 LTT index for the recombinant 65AD HSP of BCG .
triggering molecule for BCG/PPD-specific Tc cells during primary in vitro restimu-
lation .
In mice, Tc cells are an important component oftheimmune response to mycobac-
teria (3) . We have recently found that in humans, as well, mycobacteria are very
potent inducers ofantigen-specificCTLthat lyse monocytes (2)andthat these effector
cells, in parallel with lysing infected target cells, also kill intracellularly located live
mycobacteria (Kumararatne, D . S., B . Kale Ab, R. Kiessling, P . Converse, and
T. Ottenhoff, unpublished results) . This suggests that Tc cells maybe pivotal effector
cells in the actual protection against mycobacterial infections . The fact that the recom-
binant 65-kD HSP ofBCG expresses immunodominant epitopes for peripheral Tc
cells (this study) as well as B cells (6, 7) and Th (6-8) in a significant number of
individuals renders this proteinaseemingly interestingcandidate for subunit vaccines .
The recombinant 65-kD HSP of BCG was only immunodominant in ±20% of
the individuals tested and we are presently trying to define the antigens of BCG
Individual
Stimulating
antigen
LTT
index` E/T ratio PPD
Percent
monocytes
Recombinant
65-kD
HSP BCG
pecific lysis of
pulsed with :
Tetanus
toxoid
No
antigen
1 BCG 177 50 :1 52 52 ND 19
15 :1 53 43 ND 11
5 :1 44 35 ND 11
Recombinant 65 40 :1 ND 58 ND 41
65-kD BCG 12 :1 ND 53 ND 37
4 :1 ND 40 ND 14
2 PPD 112 40 :1 69 62 ND 29
12 :1 67 58 ND 22
4:1 57 52 ND 14
Recombinant 18 40 :1 50 63 ND 41
65-kD BCG 12 :1 60 61 ND 35
4 :1 56 57 ND 25
3 PPD 155 50 :1 45 29 21 20
15 :1 57 22 19 12
5 :1 38 16 0 5
Recombinant 18 25 :1 33 37 23 20
65-kD BCG 8 :1 19 26 12 10
2 :1 9 10 2 1
4 PPD 19/<lt 30 :1 54 5 21 17
9 :1 38 0 12 7
3 :1 25 0 7 350 -
I
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FIGURE I .
￿
Effect ofdepletion ofcytolyticeffectors for different cell surface markers with marker-
specific mAb-coated magnetic beads on specific lysis ofPPD pulsed (hatched bars), recombinant
65-kD HSP of BCG-pulsed (open bars), or -nonpulsed (dotted bars) monocytes.
that can induce cytotoxic cells in thoseBCG responders that do not respond to the
recombinant 65-kD HSP .
An interesting observation was the remarkably high level of killing of autologous
nonpulsed monocytes by recombinant 65-kD-induced cytotoxic cells . The former
effector cells also strongly expressed the Leu-19 (HNK-1) marker as well as strong
lytic activity against tumor cell lines(unpublished observations) . An important and
clinically relevant side effect ofan immune response primarily focussed to the recom-
binant 65-kDHSP might thus be self (specific or nonspecific) reactivity that could
result in tissue destruction, an essential featureof tuberculosis and tuberculoidleprosy .
Several other studies support a pathological role for the recombinant 65-kD HSP:
adjuvant arthritis can be induced in Lewis rats by recombinant 65-kD HSP-reactive
T cell clones (9) . T cells from rheumatoid arthritis patients recognize anM . tubercu-
losis fraction (10) that is probably enriched for the recombinant 65-kD HSP T cell
clones from tuberculoid (high responder) leprosy patients also frequently recognize
the same HSP (7) .
Future studies will have to determine whether the 65-kD determinants that are
recognized by protective Tc cells and Th can be dissociated from the determinants
that induce autoreactive T cell and non-T cell cytotoxic effector cells .
Summary
Since little is known about Tc cells in thehuman immune response to intracellular
parasites, we have studied the role ofTc cells in response toM . bovis Bacillus Calmette-
Guerin (BCG) . Donors whose PBMC responded to BCG, purified protein deriva-
tive (PPD), and the recombinant 65-kD heat shock protein (HSP) of BCG gener-1952
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ated BCG/PPD-specific CD4' effector T lymphocytes that lysed PPD as well as
recombinant 65-kD-pulsed monocytes . Nonpulsed or irrelevant antigen-pulsed target
cells were lysed to a much lower but still significant . extent . PPD-stimulated effector
lymphocytes of a recombinant 65-kD nonresponder lysed PPD but not recombinant
65-kD-pulsed monocytes .
Recombinant 65-kD-educated effector lymphocytes lysed both recombinant 65-
kD- and PPD-pulsed monocytes . In addition, these effector cells efficiently lysed
nonpulsed target cells . These results demonstrate that in recombinant 65-kD
responders, the recombinant 65-kD HSP of BCG is an immunodominant target
as well as a triggering molecule for BCG/PPD-specific CD4+ cytotoxic T cells that
lyse autologous monocytes . The implications of these findings with respect to the
role of the 65-kD HSP in autoimmunity are discussed .
We thank the ALERT doctors, and Mrs . Asrat Tilahun and Mrs . Mulunesh Negash for their
help .
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